BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24962179)

  • 1. Histopathological predictors for local recurrence in patients with T3 and T4 rectal cancers without preoperative chemoradiotherapy.
    Akagi Y; Hisaka T; Mizobe T; Kinugasa T; Ogata Y; Shirouzu K
    J Surg Oncol; 2014 Nov; 110(6):739-44. PubMed ID: 24962179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
    Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Janjan NA; Delclos ME; Krishnan S; Levy LB; Ellis LM; Crane CH
    Am J Clin Oncol; 2006 Jun; 29(3):219-24. PubMed ID: 16755173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
    Madbouly KM; Hussein AM; Abdelzaher E
    Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.
    den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ
    Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection.
    Luna-Pérez P; Bustos-Cholico E; Alvarado I; Maffuz A; Rodríguez-Ramírez S; Gutiérrez de la Barrera M; Labastida S
    J Surg Oncol; 2005 Apr; 90(1):20-5. PubMed ID: 15786412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting oncologic outcomes by stratifying mesorectal extension in patients with pT3 rectal cancer: a Japanese multi-institutional study.
    Akagi Y; Shirouzu K; Fujita S; Ueno H; Takii Y; Komori K; Ito M; Sugihara K;
    Int J Cancer; 2012 Sep; 131(5):1220-7. PubMed ID: 22025276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local recurrence in rectal cancer can be predicted by histopathological factors.
    Dresen RC; Peters EE; Rutten HJ; Nieuwenhuijzen GA; Demeyere TB; van den Brule AJ; Kessels AG; Beets-Tan RG; van Krieken JH; Nagtegaal ID
    Eur J Surg Oncol; 2009 Oct; 35(10):1071-7. PubMed ID: 19364631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer.
    Shin R; Jeong SY; Yoo HY; Park KJ; Heo SC; Kang GH; Kim WH; Park JG
    Dis Colon Rectum; 2012 Dec; 55(12):1220-8. PubMed ID: 23135579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
    Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
    Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study.
    Taylor FG; Quirke P; Heald RJ; Moran BJ; Blomqvist L; Swift IR; Sebag-Montefiore D; Tekkis P; Brown G;
    J Clin Oncol; 2014 Jan; 32(1):34-43. PubMed ID: 24276776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence.
    Akasu T; Takawa M; Yamamoto S; Ishiguro S; Yamaguchi T; Fujita S; Moriya Y; Nakanishi Y
    Ann Surg Oncol; 2008 Oct; 15(10):2668-76. PubMed ID: 18618181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision.
    Lee JH; Jang HS; Kim JG; Cho HM; Shim BY; Oh ST; Yoon SC; Kim YS; Choi BO; Kim SH
    Ann Surg Oncol; 2012 Apr; 19(4):1213-21. PubMed ID: 21935746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer.
    Baik SH; Kim NK; Lee YC; Kim H; Lee KY; Sohn SK; Cho CH
    Ann Surg Oncol; 2007 Feb; 14(2):462-9. PubMed ID: 17096053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
    Madbouly KM; Abbas KS; Hussein AM
    Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
    Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
    Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone.
    Nissan A; Stojadinovic A; Shia J; Hoos A; Guillem JG; Klimstra D; Cohen AM; Minsky BD; Paty PB; Wong WD
    J Clin Oncol; 2006 Sep; 24(25):4078-84. PubMed ID: 16943525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic analysis of middle and lower rectal cancer with different degrees of infiltration in mesorectum].
    Zhuo HQ; Zhou YB; Lü L; Zhou J; Yang WY; Li YJ
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):820-2. PubMed ID: 19595121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.